Israel Viral Respiratory Infections Treatment Market to 2032
Overview
The Israel Viral Respiratory Infections Treatment Market is expected to reach a 650.41 USD Million by 2032 and is projected to grow at a CAGR of 7.42% from 2025 to 2032.
Revenue, 2024 (USD Million)
412.03
Forecast, 2032 (USD Million)
650.41
CAGR, 2024 - 2032
7.42%
Report Coverage
Israel
Israel Viral Respiratory Infections Treatment Market 2018-2032 USD Million
Israel Viral Respiratory Infections Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 412.03 USD Million
- Projected Market Size (2032): 650.41 USD Million
- CAGR (2025-2032): 7.42%
Key Findings of Israel Viral Respiratory Infections Treatment Market
- The Israel Viral Respiratory Infections Treatment Market was valued at 412.03 USD Million in 2024.
- The Israel Viral Respiratory Infections Treatment Market is likely to grow at a CAGR of 7.42% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription Based in Type Segment accounted for the largest share of the market with a revenue of 317.41 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 8.13% during the forecast period from 2024 to 2032.
Israel Viral Respiratory Infections Treatment Market Scope
Israel Viral Respiratory Infections Treatment Market Segmentation & Scope
Disease Type
- Covid
- Rhinovirus (Common Cold)
- Respiratory Syncytial Virus (RSV)
- Influenza (FLU)
- Others
- Enterovirus
- Adenoviruses
- Parainfluenza
Route of Administration
- Injectable
- Oral
- Nasal
Type
- OTC
- Prescription Based
Treatment Type
- Others
- Monoclonal Antibdodies
- Antiviral Medications
- Non-Steroidal Anti-Inflammatory (NSAIDs)
- Vaccine
End User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Home Care Settings
- Research Institutes and Academic Centers
Gender
- Female
- Male
Population
- Adults
- Pediatric
- Geriatric
Infection Type
- Upper Respiratory Infections
- Lower Respiratory Infections
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Israel Viral Respiratory Infections Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 412.03 USD Million |
| Market Value in 2032 | 650.41 USD Million |
| CAGR (2025-2032) | 7.42% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease Type,Route of Administration,Type,Treatment Type,End User,Gender,Population,Infection Type,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Israel, leading in terms of revenue 412.03 USD Million in 2024
- Key Country: Israel, leading in terms of revenue with value of 412.03 USD Million in 2024.
Segments and Scope
-
Israel Viral Respiratory Infections Treatment Market to 2032, By Disease Type
- Rhinovirus (Common Cold) is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 87.31 USD Million in the year 2024.
- Rhinovirus (Common Cold) is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 7.24 % in forecast period 2025-2032.
-
Israel Viral Respiratory Infections Treatment Market to 2032, By Route of Administration
- Nasal is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 255.30 USD Million in the year 2024.
- Nasal is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 7.68 % in forecast period 2025-2032.
-
Israel Viral Respiratory Infections Treatment Market to 2032, By Type
- Prescription Based is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 317.41 USD Million in the year 2024.
- Prescription Based is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 7.55 % in forecast period 2025-2032.
-
Israel Viral Respiratory Infections Treatment Market to 2032, By Treatment Type
- Non-Steroidal Anti-Inflammatory (NSAIDs) is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 175.35 USD Million in the year 2024.
- Non-Steroidal Anti-Inflammatory (NSAIDs) is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.01 % in forecast period 2025-2032.
-
Israel Viral Respiratory Infections Treatment Market to 2032, By End User
- Hospitals is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 167.65 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.13 % in forecast period 2025-2032.
-
Israel Viral Respiratory Infections Treatment Market to 2032, By Gender
- Male is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 262.18 USD Million in the year 2024.
- Male is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 7.69 % in forecast period 2025-2032.
-
Israel Viral Respiratory Infections Treatment Market to 2032, By Population
- Geriatric is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 193.90 USD Million in the year 2024.
- Geriatric is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 7.97 % in forecast period 2025-2032.
-
Israel Viral Respiratory Infections Treatment Market to 2032, By Infection Type
- Lower Respiratory Infections is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 252.17 USD Million in the year 2024.
- Lower Respiratory Infections is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 7.77 % in forecast period 2025-2032.
-
Israel Viral Respiratory Infections Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a revenue of 207.52 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Israel Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 7.80 % in forecast period 2025-2032.
Israel Viral Respiratory Infections Treatment Market Company Share Analysis
| Company Name |
|
||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Gilead Sciences, Inc. | |||
| GSK plc. | |||
| F. Hoffmann-La Roche Ltd. | |||
Israel Viral Respiratory Infections Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Israel Viral Respiratory Infections Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Israel Viral Respiratory Infections Treatment Market is segmented based on Segmentation Disease Type,Route of Administration,Type,Treatment Type,End User,Gender,Population,Infection Type,Distribution Channel.
Israel Viral Respiratory Infections Treatment Market was valued at USD 412.03(Revenue in USD Million) in 2022.
Israel Viral Respiratory Infections Treatment Market is projected to grow at a CAGR of 7.42% during the forecast period of 2024 to 2032.
The Prescription Based segment is expected to dominate the Israel Viral Respiratory Infections Treatment Market, holding a largest market share of 317.41 USD Million in 2024
Israel Viral Respiratory Infections Treatment Market Scope
Israel Viral Respiratory Infections Treatment Market Segmentation & Scope
Disease Type
- Covid
- Rhinovirus (Common Cold)
- Respiratory Syncytial Virus (RSV)
- Influenza (FLU)
- Others
- Enterovirus
- Adenoviruses
- Parainfluenza
Route of Administration
- Injectable
- Oral
- Nasal
Type
- OTC
- Prescription Based
Treatment Type
- Others
- Monoclonal Antibdodies
- Antiviral Medications
- Non-Steroidal Anti-Inflammatory (NSAIDs)
- Vaccine
End User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Home Care Settings
- Research Institutes and Academic Centers
Gender
- Female
- Male
Population
- Adults
- Pediatric
- Geriatric
Infection Type
- Upper Respiratory Infections
- Lower Respiratory Infections
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Israel Viral Respiratory Infections Treatment Market is segmented based on Segmentation Disease Type,Route of Administration,Type,Treatment Type,End User,Gender,Population,Infection Type,Distribution Channel.
Israel Viral Respiratory Infections Treatment Market was valued at USD 412.03(Revenue in USD Million) in 2022.
Israel Viral Respiratory Infections Treatment Market is projected to grow at a CAGR of 7.42% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Viral Respiratory Infections Treatment Market for final year is USD 650.41 (USD Million).
Israel Viral Respiratory Infections Treatment Market Company Profiling
Frequently Asked Questions
The Israel Viral Respiratory Infections Treatment Market is segmented based on Segmentation Disease Type,Route of Administration,Type,Treatment Type,End User,Gender,Population,Infection Type,Distribution Channel.
Israel Viral Respiratory Infections Treatment Market was valued at USD 412.03(Revenue in USD Million) in 2022.
Israel Viral Respiratory Infections Treatment Market is projected to grow at a CAGR of 7.42% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Viral Respiratory Infections Treatment Market for final year is USD 650.41 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.